The impact of polyvascular disease on long-term outcome in percutaneous coronary intervention patients

European Journal of Clinical Investigation

Volumn 44, Issue 3, 2014, Pages 231-239

  van der Meer, Manon G ^a   Cramer, Maarten J ^a   van der Graaf, Yolanda ^a   Appelman, Yolande ^b   Doevendans, Pieter A ^a   Nathoe, Hendrik M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Coronary artery disease; Percutaneous coronary intervention; Polyvascular disease; Prognosis

Indexed keywords

CORONARY ARTERY DISEASE; PERCUTANEOUS CORONARY INTERVENTION; POLYVASCULAR DISEASE; PROGNOSIS;

AGED; AORTIC ANEURYSM, ABDOMINAL; CARDIOVASCULAR DISEASES; CAROTID STENOSIS; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MICROVESSELS; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL ARTERIAL DISEASE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RENAL ARTERY; STROKE; TREATMENT OUTCOME;

EID: 84893764834     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12222     Document Type: Article

References (32)

1. Kannel WB. Overview of atherosclerosis. Clin Ther 1998;20(Suppl B):B2-17.
2. Cotter G, Cannon CP, McCabe CH, Michowitz Y, Kaluski E, Charlesworth A et al. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study. Am Heart J 2003;145:622-7.
3. Naidu SS, Vlachos H, Faxon D, Jacobs AK, Selzer F, Detre K et al. Usefulness of noncoronary vascular disease in predicting adverse events in the year following percutaneous coronary intervention. Am J Cardiol 2005;95:575-80.
4. Singh M, Lennon RJ, Darbar D, Gersh BJ, Holmes DR Jr, Rihal CS. Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents. Mayo Clin Proc 2004;79:1113-8.
5. Burek KA, Sutton-Tyrrell K, Brooks MM, Naydeck B, Keller N, Sellers MA et al. Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 1999;34:716-21.
6. Simons PC, Algra A, van de Laak MF, Grobbee DE, van der Graaf Y. Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol 1999;15:773-81.
7. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.
8. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-536.
9. Ndrepepa G, Tada T, Fusaro M, Cassese S, King L, Hadamitzky M et al. Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease. Clin Res Cardiol 2012;101:1003-11.
10. Huang G, Zhao JL, Du H, Lan XB, Yin YH. Coronary score adds prognostic information for patients with acute coronary syndrome. Circ J 2010;74:490-5.
11. Uchida Y, Ichimiya S, Ishii H, Kanashiro M, Watanabe J, Yoshikawa D et al. Impact of plaque burden in the left main coronary artery determined by intravascular ultrasound on cardiovascular events in a Japanese population undergoing percutaneous coronary intervention. Am J Cardiol 2012;109:352-8.
12. Bhatt DL, Peterson ED, Harrington RA, Ou FS, Cannon CP, Gibson CM et al. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. Eur Heart J 2009;30:1195-202.
13. Mukherjee D, Eagle KA, Kline-Rogers E, Feldman LJ, Juliard JM, Agnelli G et al. Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events). Am J Cardiol 2007;100:1-6.
14. Suarez C, Zeymer U, Limbourg T, Baumgartner I, Cacoub P, Poldermans D et al. Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry. Vasc Med 2010;15:259-65.
15. Narins CR, Zareba W, Moss AJ, Marder VJ, Ridker PM, Krone RJ et al. Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction. Arch Intern Med 2004;164:440-6.
16. Niccoli G, Biasucci LM, Biscione C, Fusco B, Porto I, Leone AM et al. Independent prognostic value of C-reactive protein and coronary artery disease extent in patients affected by unstable angina. Atherosclerosis 2008;196:779-85.
17. Zebrack JS, Muhlestein JB, Horne BD, Anderson JL. Intermountain Heart Collaboration Study Group. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 2002;39:632-7.
18. Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K et al. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol 2013;62:397-408.
19. Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 2005;352:29-38.
20. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005;352:20-8.
21. Lee TC, Goodman SG, Yan RT, Grondin FR, Welsh RC, Rose B et al. Disparities in management patterns and outcomes of patients with non-ST-elevation acute coronary syndrome with and without a history of cerebrovascular disease. Am J Cardiol 2010;105:1083-9.
22. Wong JA, Goodman SG, Yan RT, Wald R, Bagnall AJ, Welsh RC et al. Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction. Eur Heart J 2009;30:549-57.
23. Makowsky MJ, McAlister FA, Galbraith PD, Southern DA, Ghali WA, Knudtson ML et al. Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy. Am Heart J 2008;155:348-55.
24. Puri R, Nissen SE, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R et al. Factors underlying regression of coronary atheroma with potent statin therapy. Eur Heart J 2013;34:1818-25.
25. Nakata S, Yokoi Y, Matsumoto R, Shirai N, Otsuka R, Sugioka K et al. Long-term cardiovascular outcomes following ischemic heart disease in patients with and without peripheral vascular disease. Osaka City Med J 2008;54:21-30.
26. Romano G, Corrado E, Muratori I, Novo G, Andolina G, Cospite V et al. Carotid and peripheral atherosclerosis in patients who underwent primary percutaneous coronary intervention and outcome associated with multifocal atherosclerosis. Int Angiol 2006;25:389-94.
27. Bendermacher BL, Teijink JA, Willigendael EM, Bartelink ML, Peters RJ, Langenberg M et al. Applicability of the ankle-brachial-index measurement as screening device for high cardiovascular risk: an observational study. BMC Cardiovasc Disord 2012;12:59.
28. Leng GC, Fowkes FG, Lee AJ, Dunbar J, Housley E, Ruckley CV. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 1996;313:1440-4.
29. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993;87:II56-65.
30. Kim LG, Scott RAP, Ashton HA, Thompson SG. Multicentre Aneurysm Screening Study Group. A sustained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med 2007; 146: 699-706.
31. Quill DS, Colgan MP, Sumner DS. Ultrasonic screening for the detection of abdominal aortic aneurysms. Surg Clin North Am 1989;69:713-20.
32. Hallan SI, Stevens P. Screening for chronic kidney disease: which strategy? J Nephrol 2010;23:147-55.